Montauk Renewables, Inc. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; unaudited. Unless otherwise noted, dollar amounts are in millions.
Business context
Montauk develops and operates facilities that capture biogas, primarily from landfills and agricultural waste, and convert it into renewable natural gas (RNG) or renewable electricity. Revenue includes sales of energy and related environmental attributes, notably D3 RINs. The company reported 14 operating projects across eight states.
Financial and operating performance
- Revenue: $38.8, up 102.5% from $19.2. RNG revenue was $34.0, up 129.9%; renewable electricity revenue was $4.8, up 9.8%.
- Profitability: Operating income was $2.4 versus an operating loss of $14.2. Net income was $1.9, or $0.01 per diluted share, versus a net loss of $3.8, or $0.03 per share. Operating and net margins were approximately 6.1% and 4.8%, respectively.
- Non-GAAP results: Adjusted EBITDA was $9.5 versus negative $8.4. The company cautions that EBITDA and Adjusted EBITDA are supplemental measures, not substitutes for GAAP results or cash flow.
- Cash flow and investment: Operating cash flow was $14.3 versus cash used of $11.8. Capital expenditures were $22.0, making operating cash flow less capital expenditures negative $7.7. Investing cash outflow totaled $22.8; financing cash outflow was $2.0, principally debt repayment.
- Liquidity: Cash and equivalents were $63.3 at quarter-end, down from $73.8 at year-end; restricted cash was $0.5. Available revolving-credit capacity was $117.5, with no revolver borrowings and $2.5 of letters of credit reducing availability.
- Debt: Term-loan principal was $62.0, down from $64.0 at year-end. The balance-sheet carrying amount of total debt was $61.5 after issuance costs. The stated interest rate was 6.18%; the company reported covenant compliance.
- Other metrics: RNG production was 1.411 million MMBtu, up 4.4%; renewable electricity generation was 54 thousand MWh, up 17.4%. Average realized RIN price was $3.25, up 61.7% year over year.
Changes versus Q1 2023
Revenue growth primarily reflected more RIN sales and higher realized RIN prices, rather than a comparable increase in total RNG output. The company sold 7,889 thousand RINs versus 2,949 thousand a year earlier. It said the prior-year period included a strategic decision not to self-market a significant amount of RINs. In Q1 2024, it also chose not to transfer all available current-year RINs and reported 3,351 thousand generated but unsold at quarter-end. Natural-gas commodity pricing was lower, while RNG segment operating expenses increased 22.5%. Total operating expenses increased 9.3%, slower than revenue.
The prior-year comparison also includes a $12.1 million income-tax benefit in Q1 2023, versus $0.4 million tax expense in Q1 2024; this affects the net-income comparison. The company’s revenue mix shifted toward point-in-time environmental-attribute sales, which represented 74% of revenue versus 45% a year earlier.
Outlook, commentary and risks
- Management said existing cash, operating cash flows and credit availability should be sufficient for debt service and anticipated required capital expenditures over the next 12–24 months, while noting that business and operational risks could adversely affect liquidity.
- For 2024, the company estimated non-development capital expenditures of $14–17 million and development expenditures of $135–150 million. Q1 capital expenditures were $22.0 million.
- Projects under development include Montauk Ag in North Carolina, a second Apex RNG facility, Blue Granite, Bowerman and a biogenic CO2 project with European Energy. Current target dates include second Apex in Q1 2025, Blue Granite and Bowerman in 2026, and initial CO2 delivery in 2027. Montauk Ag is expected to begin generating revenue in 2025; timing, costs and regulatory approvals remain uncertain.
- Montauk Ag’s estimated first-phase investment is $140–160 million. Management cited feedstock, utility interconnection, regulatory designation, construction schedule and cost risks. It expects to pursue commissioning of processing lines from 2024 through 2025.
- Rumpke wellfield conditions and a process-equipment failure reduced production; mitigation efforts are expected to continue through 2024. McCarty has received lower feedstock volumes and elevated nitrogen following changes to the landfill host’s wellfield system.
- EPA biogas regulatory reforms require existing participants to comply by January 1, 2025, with registration updates due by October 1, 2024. Proposed California LCFS changes could alter credit supply, pricing and project economics; rules were not final at the filing date.
- Four customers each represented more than 10% of Q1 revenue; the largest accounted for 40.6%, creating customer concentration risk. Revenue and profitability also depend on environmental-attribute prices, regulation, feedstock availability and project output.
Unusual items and contingencies
The company agreed to sell rights and property at a renewable-electricity site for $1.0 million, with an effective sale date of October 1, 2024. It ceased operations there and recorded a $0.3 million impairment; it also recorded $0.2 million of impairment for obsolete or inoperable RNG equipment. Management reported no material pending legal proceedings and believed operations complied in all material respects with applicable environmental requirements, while noting future compliance costs could be significant. No material subsequent events were reported.
Most important facts for investors to verify
- Whether revenue and earnings growth are sustained, given their significant dependence on RIN monetization, environmental-attribute prices and timing of RIN sales.
- Whether unsold RIN inventory is transferred, at what realized price, and how EPA rule changes affect generation and registration.
- Progress, total funding needs and commissioning schedules for Montauk Ag and other development projects, particularly the $135–150 million 2024 development-capex estimate.
- Whether Rumpke and McCarty feedstock and operating issues improve, and whether production targets are achieved.
- Liquidity and covenant headroom as capital spending proceeds, including the term loan’s scheduled amortization and the large final payment due in late 2026.
- Customer concentration, environmental-attribute market exposure, regulatory developments and project interconnection risks.